drugset / Trial / NCT01940952
Zydena on Cognitive Function of Alzheimer's Disease Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Zydena (Udenafil) has positive effect on cognitive function in patients with Alzheimer's disease. This study is a randomized, double blind, placebo-controlled multicenter study.
Timeline
- Start
- 2013-09
- Primary completion
- 2015-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Udenafil | Small molecule | 50 mg | — |
| Comparator | Udenafil | Small molecule | 100 mg | — |
| Comparator | Donepezil | Small molecule | 5 mg | — |
| Comparator | Donepezil | Small molecule | 10 mg | — |